Hansa Raj KC

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

Researcher

Arkansas State University

Faculty Researcher

8 h-index 9 pubs 185 cited

Research Areas

Biomedical Subjects

Links

Research Group

OverviewAI-generated summary

Hansa Raj KC's research focuses on the design, synthesis, and evaluation of novel pyrazole derivatives as potential therapeutic agents, primarily investigating their antibacterial properties. His work has led to the development of compounds targeting specific bacterial processes, such as fatty acid biosynthesis, and has shown efficacy against a range of pathogens, including drug-resistant strains like Methicillin-Resistant Staphylococcus aureus (MRSA).

KC has published on pyrazole derivatives with substitutions designed to enhance their activity against staphylococci, enterococci, and Acinetobacter baumannii. His research also includes the synthesis of other heterocyclic compounds, such as thiazole-fused bisnoralcohol derivatives, for potential therapeutic applications. He collaborates with several researchers at Arkansas State University, including Mohammad A. Alam, David F. Gilmore, and Subrata Roy, with whom he has co-authored multiple publications. His h-index is 8, with a total of 9 publications and 175 citations.

Metrics

h-index: 8
Publications: 9
Citations: 185

Selected Publications

Efficient Synthesis of Thiazole-Fused Bisnoralcohol Derivatives as Potential Therapeutic Agents (2024)

ACS Omega 4 citations DOI OpenAlex
Development and Antibacterial Properties of 4-[4-(Anilinomethyl)-3-phenylpyrazol-1-yl]benzoic Acid Derivatives as Fatty Acid Biosynthesis Inhibitors (2023)

Journal of Medicinal Chemistry 16 citations DOI OpenAlex
Development of 4-[4-(Anilinomethyl)-3-phenyl-pyrazol-1-yl] Benzoic Acid Derivatives as Potent Anti-Staphylococci and Anti-Enterococci Agents (2022)

Antibiotics 9 citations DOI OpenAlex
Novel Pyrazoles As Potent Growth Inhibitors of Staphylococci, Enterococci and <i>Acinetobacter Baumannii</i> Bacteria (2021)

Future Medicinal Chemistry 13 citations DOI OpenAlex
Design, synthesis, and antibacterial activity of <i>N</i> -(trifluoromethyl)phenyl substituted pyrazole derivatives (2021)

RSC Medicinal Chemistry 33 citations DOI OpenAlex
Synthesis of 3,5-Bis(trifluoromethyl)phenyl-Substituted Pyrazole Derivatives as Potent Growth Inhibitors of Drug-Resistant Bacteria (2021)

Molecules 8 citations DOI OpenAlex
Synthesis of 4,4′-(4-Formyl-1H-pyrazole-1,3-diyl)dibenzoic Acid Derivatives as Narrow Spectrum Antibiotics for the Potential Treatment of Acinetobacter Baumannii Infections (2020)

Antibiotics 20 citations DOI OpenAlex
Design and synthesis of 4-[4-formyl-3-(2-naphthyl)pyrazol-1-yl]benzoic acid derivatives as potent growth inhibitors of drug-resistant Staphylococcus aureus (2020)

The Journal of Antibiotics 21 citations DOI OpenAlex
Synthesis and Antimicrobial Studies of Coumarin-Substituted Pyrazole Derivatives as Potent Anti-Staphylococcus aureus Agents (2020)

Molecules 61 citations DOI OpenAlex